Mankind Pharma to acquire Combihale and Daffy

Mankind Pharma has inked a pact with Dr. Reddy’s Laboratories for the acquisition of its two brands, Combihale and Daffy. Daffy is a soap-free moisturizing bar for infants, and Combihale is used for the treatment of asthma and chronic obstructive pulmonary disease. Mankind Pharma has also said that Combihale is valued at Rs 900 crore, growing at 14%. The company expects to strengthen the company’s presence in the inhalation respiratory market segment. According to the terms of the definitive agreement, Mankind Pharma will take over the manufacturing, marketing, and distribution of both the products in India. As per the terms of the definitive agreement executed between the companies, Mankind Pharma will take over the manufacturing, marketing, and distribution of both products in India. The whole integration and transition of the brands are expected to be completed by March this year.  The President of Mankind Pharma, Atish Majumdar has said that we believe these brands have adequate potential to grow in the Indian market and the best part of the acquisition is that both the brands perfectly fit in their portfolio, and provides us an opportunity to grow and build the respiratory and dermatology business further.